Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway

References

• Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015 6 9; 313(22): 2263–2273. doi:10.1001/jama.2015.5370
   Google Scholar
• Arab JP , Barrera F , Gallego C , et al. High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients. Ann Hepatol . 2016;15(5):721–728. doi:10.5604/16652681.1212434
   Web of Science ®Google Scholar
• Ballestri S , Zona S , Targher G , et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol . 2016;31(5):936–944. doi:10.1111/jgh.13264 26667191
   PubMed Web of Science ®Google Scholar
• Smith BW , Adams LA . Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol . 2011;7(8):456–465. doi:10.1038/nrendo.2011.72 21556019
   PubMed Web of Science ®Google Scholar
• Porepa L , Ray JG , Sanchez-Romeu P , Booth GL . Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. Cmaj . 2010;182(11):E526–31. doi:10.1503/cmaj.092144 20566726
   PubMed Web of Science ®Google Scholar
• Chen J , Zhao H , Ma X , et al. GLP-1/GLP-1R signaling in regulation of adipocyte differentiation and lipogenesis. Cell Physiol Biochem . 2017;42(3):1165–1176. doi:10.1159/000478872 28668964
   PubMedGoogle Scholar
• He Q , Sha S , Sun L , Zhang J , Dong M . GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway. Biochem Biophys Res Commun . 2016;476(4):196–203. doi:10.1016/j.bbrc.2016.05.086 27208776
   PubMed Web of Science ®Google Scholar
• Wajcberg E , Amarah A . Liraglutide in the management of type 2 diabetes. Drug Des Devel Ther . 2010;4:279–290. doi:10.2147/DDDT.S10180
   PubMed Web of Science ®Google Scholar
• Samson SL , Bajaj M . Potential of incretin-based therapies for non-alcoholic fatty liver disease. J Diabetes Complications . 2013;27(4):401–406. doi:10.1016/j.jdiacomp.2012.12.005 23352496
   PubMed Web of Science ®Google Scholar
• Sinaiko AR , Caprio S . Insulin resistance. J Pediatr . 2012;161(1):11–15. doi:10.1016/j.jpeds.2012.01.012 22336575
   PubMed Web of Science ®Google Scholar
• Kotzka J , Muller-Wieland D . Sterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance? Expert Opin Ther Targets . 2004;8(2):141–149. doi:10.1517/14728222.8.2.141 15102555
   PubMed Web of Science ®Google Scholar
• Zheng F , Cai Y . Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-gamma and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet. Lipids Health Dis . 2019;18(1):6. doi:10.1186/s12944-018-0933-z 30611282
   PubMed Web of Science ®Google Scholar
• Guo S . Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol . 2014;220(2):T1–T23. doi:10.1530/JOE-13-0327 24281010
   PubMed Web of Science ®Google Scholar
• Boucher J , Kleinridders A , Kahn CR . Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol . 2014;6(1). doi:10.1101/cshperspect.a009191
   Web of Science ®Google Scholar
• Roncero I , Alvarez E , Acosta C , et al. Insulin-receptor substrate-2 (irs-2) is required for maintaining glucokinase and glucokinase regulatory protein expression in mouse liver. PLoS One . 2013;8(4):e58797. doi:10.1371/journal.pone.0058797 23560040
   PubMed Web of Science ®Google Scholar
• Yoneyama Y , Lanzerstorfer P , Niwa H , et al. IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling. eLife . 2018;7. doi:10.7554/eLife.42270
   Web of Science ®Google Scholar
• Kubota N , Tobe K , Terauchi Y , et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes . 2000;49(11):1880–1889.11078455
   PubMed Web of Science ®Google Scholar
• Talbot K . Brain insulin resistance in alzheimer’s disease and its potential treatment with GLP-1 analogs. Neurodegener Dis Manag . 2014;4(1):31–40. doi:10.2217/nmt.13.73 24640977
   PubMedGoogle Scholar
• Talbot K , Wang HY . The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in alzheimer’s disease. Alzheimer’s Dementia . 2014;10(1 Suppl):S12–25. doi:10.1016/j.jalz.2013.12.007
   PubMed Web of Science ®Google Scholar
• Liang Y , Li Z , Liang S , et al. Hepatic adenylate cyclase 3 is upregulated by liraglutide and subsequently plays a protective role in insulin resistance and obesity. Nutr Diabetes . 2016;6:e191. doi:10.1038/nutd.2015.37 26807509
   PubMed Web of Science ®Google Scholar
• Nagarajan P , Mahesh Kumar MJ , Venkatesan R , Majundar SS , Juyal RC . Genetically modified mouse models for the study of nonalcoholic fatty liver disease. World J Gastroenterol . 2012;18(11):1141–1153. doi:10.3748/wjg.v18.i11.1141 22468076
   PubMed Web of Science ®Google Scholar
• Arisqueta L , Navarro-Imaz H , Labiano I , Rueda Y , Fresnedo O . High fat diet overfeeding promotes non-detrimental liver steatosis in female mice. Am J Physiol Gastrointestinal Liver Physiol . 2018. doi:10.1152/ajpgi.00022.2018
   Web of Science ®Google Scholar
• Xu H , Zhou Y , Liu Y , et al. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis. J Endocrinol . 2016;229(2):133–144. doi:10.1530/JOE-15-0409 26941037
   PubMed Web of Science ®Google Scholar
• Ipsen DH , Rolin B , Rakipovski G , et al. Liraglutide decreases hepatic inflammation and injury in advanced lean non-alcoholic steatohepatitis. Basic Clin Pharmacol Toxicol . 2018;123(6):704–713. doi:10.1111/bcpt.2018.123.issue-6 29953740
   PubMed Web of Science ®Google Scholar
• Zhu W , Feng PP , He K , Li SW , Gong JP . Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet. Biochem Biophys Res Commun . 2018;505(2):523–529. doi:10.1016/j.bbrc.2018.09.134 30269815
   PubMed Web of Science ®Google Scholar
• Tian F , Zheng Z , Zhang D , He S , Shen J . Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease. Biosci Rep . 2018;38(6). doi:10.1042/BSR20181304
   Web of Science ®Google Scholar
• Postic C , Girard J . Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest . 2008;118(3):829–838. doi:10.1172/JCI34275 18317565
   PubMed Web of Science ®Google Scholar
• Fan R , Kang Z , He L , Chan J , Xu G , Maedler K . Exendin-4 improves blood glucose control in both young and aging normal non-diabetic mice, possible contribution of beta cell independent effects. PLoS One . 2011;6(5):e20443. doi:10.1371/journal.pone.0020443 21655268
   PubMed Web of Science ®Google Scholar
• Qin Y , Chen M , Yang Y , et al. Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway. Mol Med Rep . 2018;17(5):7372–7380. doi:10.3892/mmr.2018.8737 29568881
   PubMed Web of Science ®Google Scholar
• Cho YM , Fujita Y , Kieffer TJ . Glucagon-like peptide-1: glucose homeostasis and beyond. Annu Rev Physiol . 2014;76:535–559. doi:10.1146/annurev-physiol-021113-170315 24245943
   PubMed Web of Science ®Google Scholar
• Yaribeygi H , Farrokhi FR , Butler AE , Sahebkar A . Insulin resistance: review of the underlying molecular mechanisms. J Cell Physiol . 2019 June;234(6):8152–8161. doi:10.1002/jcp.27603. Epub 2018 Oct 14.
   Web of Science ®Google Scholar
• Fatani S , Itua I , Clark P , Wong C , Naderali EK . The effects of diet-induced obesity on hepatocyte insulin signaling pathways and induction of non-alcoholic liver damage. Int J Gen Med . 2011;4:211–219. doi:10.2147/IJGM.S17376 21475632
   PubMedGoogle Scholar
• Friedman JE , Ishizuka T , Liu S , et al. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am J Physiol . 1997;273(5 Pt 1):E1014–23.9374689
   PubMedGoogle Scholar
• Tagawa H , Irie J , Itoh A , et al. Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver. Diabetes Res Clin Pract . 2015;109(1):85–94. doi:10.1016/j.diabres.2015.04.025 25981325
   PubMed Web of Science ®Google Scholar
• Balaji V , Pokrzywa W , Hoppe T . Ubiquitylation pathways in insulin signaling and organismal homeostasis. BioEssays . 2018;40(5):e1700223. doi:10.1002/bies.v40.5 29611634
   PubMed Web of Science ®Google Scholar